Azurion 7 M12
Payments companies reported to CMS as associated with Azurion 7 M12. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Azurion 7 M12, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Azurion 7 M12
These are the largest totals companies reported as associated with Azurion 7 M12. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ziad Ali | New York, NY | Internal Medicine | $584.03 |
| Raid Saco | Dearborn, MI | Internal Medicine | $152.18 |
| Wilberto Lopez | Lake Mary, FL | Cardiovascular Disease | $91.11 |
| Mulugeta Fissha | Lake Mary, FL | Interventional Cardiology | $91.11 |
| William David | Lake Mary, FL | Cardiovascular Disease | $91.10 |
| Jude Clancy | Middletown, CT | Clinical Cardiac Electrophysiology | $46.33 |
| Tatiana Joseph | Brighton, MA | Internal Medicine | $30.20 |
| Sonya Noor | Buffalo, NY | Vascular Surgery | $30.20 |
| Meron Teshome | Memphis, TN | Interventional Cardiology | $16.54 |
Prescribed Azurion 7 M12?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.